Plain-English translation of NCT06730529 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Thyroid Cancer research guide →This trial is testing a new imaging scan called 68Ga-FAPI PET/CT to see if it can better detect and map thyroid cancer that has spread to nearby lymph nodes before surgery. The scan uses a special tracer to light up cancer cells, helping doctors see exactly where the cancer is. Researchers will compare what the scan shows with what they find during surgery to see how accurate this new imaging method really is.
Doctors need better ways to see exactly where thyroid cancer has spread before operating, so they can remove all the cancer while protecting healthy tissue. This new imaging technique may help them plan surgery more precisely and improve treatment outcomes.
You likely qualify if…
You likely don't qualify if…
You would undergo a 68Ga-FAPI PET/CT imaging scan before your scheduled thyroid cancer surgery. The researchers will record your basic health information and medical history, then compare what the scan shows with the actual findings from your surgery to evaluate how well this new imaging method works. The entire process is designed to help doctors better understand how useful this scan is for planning thyroid cancer surgery.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China
Enrollment target
~40 participants
Started
November 2024
Primary completion
December 2029
Age range
16 Years – 80 Years
Last updated on clinicaltrials.gov in December 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jiajia Hu
Ruijin Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.